Cargando…

Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction

Low-dose dobutamine stress echocardiography (DSE) is a valuable tool to distinguish true-severe (TS) from pseudo-severe (PS) low gradient aortic valve stenosis (LGAS) in patients with reduced left ventricular ejection fraction (LVEF). However, only scanty studies reported the clinical utility of DSE...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dan, Hu, Kai, Liebner, Eva, Weidemann, Frank, Herrmann, Sebastian, Ertl, Georg, Frantz, Stefan, Nordbeck, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245091/
https://www.ncbi.nlm.nih.gov/pubmed/30039338
http://dx.doi.org/10.1007/s10554-018-1416-z
_version_ 1783372174918156288
author Liu, Dan
Hu, Kai
Liebner, Eva
Weidemann, Frank
Herrmann, Sebastian
Ertl, Georg
Frantz, Stefan
Nordbeck, Peter
author_facet Liu, Dan
Hu, Kai
Liebner, Eva
Weidemann, Frank
Herrmann, Sebastian
Ertl, Georg
Frantz, Stefan
Nordbeck, Peter
author_sort Liu, Dan
collection PubMed
description Low-dose dobutamine stress echocardiography (DSE) is a valuable tool to distinguish true-severe (TS) from pseudo-severe (PS) low gradient aortic valve stenosis (LGAS) in patients with reduced left ventricular ejection fraction (LVEF). However, only scanty studies reported the clinical utility of DSE in differentiating TS-LGAS patients with preserved LVEF. We investigated the clinical utility of DSE in LGAS patients with preserved LVEF and the echocardiographic determinants suggestive of TS-LGAS. 130 consecutive LGAS patients [indexed aortic valve area (AVA) ≤ 0.6cm(2)/m(2) and mean trans-aortic pressure gradient (PG(mean)) < 40mmHg] with preserved (≥ 50%, n = 63) and reduced (< 50%, n = 67) LVEF were included. DSE defined TS-LGAS (projected AVA ≤ 1 cm(2)) in 61.2% patients with reduced LVEF and in 68.3% patients with preserved LVEF. Multivariate logistic regression analysis showed that baseline AVA was an independent determinant of TS-LGAS both in LVEF ≥ 50% (OR 0.45, P = 0.004) and LVEF < 50% groups (OR 0.55, P = 0.005). Reduced septal and lateral mitral annular plane systolic excursion (MAPSE, OR 0.72 and 0.75, P = 0.013 and 0.016) and septal TDI-s´ were significantly associated with TS-LGAS in patients with LVEF ≥ 50%. Higher systolic pulmonary artery pressure (SPAP, OR 1.43, P = 0.045) was associated with TS-LGAS in patients with LVEF < 50%. DSE is useful to define TS-LGAS also in patients with preserved LVEF. Lower baseline AVA values are linked with TS-LGAS in both patients with reduced and preserved LVEF. Reduced MAPSE and septal TDI-s´ are suggestive of TS-LGAS in patients with preserved LVEF, while higher SPAP is associated with TS-LGAS in patients with reduced LVEF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10554-018-1416-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6245091
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-62450912018-12-04 Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction Liu, Dan Hu, Kai Liebner, Eva Weidemann, Frank Herrmann, Sebastian Ertl, Georg Frantz, Stefan Nordbeck, Peter Int J Cardiovasc Imaging Original Paper Low-dose dobutamine stress echocardiography (DSE) is a valuable tool to distinguish true-severe (TS) from pseudo-severe (PS) low gradient aortic valve stenosis (LGAS) in patients with reduced left ventricular ejection fraction (LVEF). However, only scanty studies reported the clinical utility of DSE in differentiating TS-LGAS patients with preserved LVEF. We investigated the clinical utility of DSE in LGAS patients with preserved LVEF and the echocardiographic determinants suggestive of TS-LGAS. 130 consecutive LGAS patients [indexed aortic valve area (AVA) ≤ 0.6cm(2)/m(2) and mean trans-aortic pressure gradient (PG(mean)) < 40mmHg] with preserved (≥ 50%, n = 63) and reduced (< 50%, n = 67) LVEF were included. DSE defined TS-LGAS (projected AVA ≤ 1 cm(2)) in 61.2% patients with reduced LVEF and in 68.3% patients with preserved LVEF. Multivariate logistic regression analysis showed that baseline AVA was an independent determinant of TS-LGAS both in LVEF ≥ 50% (OR 0.45, P = 0.004) and LVEF < 50% groups (OR 0.55, P = 0.005). Reduced septal and lateral mitral annular plane systolic excursion (MAPSE, OR 0.72 and 0.75, P = 0.013 and 0.016) and septal TDI-s´ were significantly associated with TS-LGAS in patients with LVEF ≥ 50%. Higher systolic pulmonary artery pressure (SPAP, OR 1.43, P = 0.045) was associated with TS-LGAS in patients with LVEF < 50%. DSE is useful to define TS-LGAS also in patients with preserved LVEF. Lower baseline AVA values are linked with TS-LGAS in both patients with reduced and preserved LVEF. Reduced MAPSE and septal TDI-s´ are suggestive of TS-LGAS in patients with preserved LVEF, while higher SPAP is associated with TS-LGAS in patients with reduced LVEF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10554-018-1416-z) contains supplementary material, which is available to authorized users. Springer Netherlands 2018-07-23 2018 /pmc/articles/PMC6245091/ /pubmed/30039338 http://dx.doi.org/10.1007/s10554-018-1416-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Liu, Dan
Hu, Kai
Liebner, Eva
Weidemann, Frank
Herrmann, Sebastian
Ertl, Georg
Frantz, Stefan
Nordbeck, Peter
Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction
title Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction
title_full Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction
title_fullStr Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction
title_full_unstemmed Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction
title_short Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction
title_sort value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245091/
https://www.ncbi.nlm.nih.gov/pubmed/30039338
http://dx.doi.org/10.1007/s10554-018-1416-z
work_keys_str_mv AT liudan valueoflowdosedobutaminestressechocardiographyondefiningtrueseverelowgradientaorticstenosisinpatientswithpreservedleftventricularejectionfraction
AT hukai valueoflowdosedobutaminestressechocardiographyondefiningtrueseverelowgradientaorticstenosisinpatientswithpreservedleftventricularejectionfraction
AT liebnereva valueoflowdosedobutaminestressechocardiographyondefiningtrueseverelowgradientaorticstenosisinpatientswithpreservedleftventricularejectionfraction
AT weidemannfrank valueoflowdosedobutaminestressechocardiographyondefiningtrueseverelowgradientaorticstenosisinpatientswithpreservedleftventricularejectionfraction
AT herrmannsebastian valueoflowdosedobutaminestressechocardiographyondefiningtrueseverelowgradientaorticstenosisinpatientswithpreservedleftventricularejectionfraction
AT ertlgeorg valueoflowdosedobutaminestressechocardiographyondefiningtrueseverelowgradientaorticstenosisinpatientswithpreservedleftventricularejectionfraction
AT frantzstefan valueoflowdosedobutaminestressechocardiographyondefiningtrueseverelowgradientaorticstenosisinpatientswithpreservedleftventricularejectionfraction
AT nordbeckpeter valueoflowdosedobutaminestressechocardiographyondefiningtrueseverelowgradientaorticstenosisinpatientswithpreservedleftventricularejectionfraction